«

»

Aetna Cancels In-Network Contract With Mental Health Startup Cerebral

The $4.8 billion startup is being investigated by the Department of Justice over its controlled dangerous substances prescribing practices.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive